Retatrutide, a dosage of 15mg, represents a potential advancement in weight management strategies. This dual GIP and GLP-1 agonist shows remarkable outcomes across clinical trials , indicating substantial decreases related to body weight . Numerous analysts suggest it could provide an effective t